Atlas Trials

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Clinical trial NCT00006113 · TERMINATED

Trial details

NCT number
NCT00006113
Sponsor
University of Southern California
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma (Skin)
Start date
1999-06-01
Primary completion
2003-05-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.